$STXS News

TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

Stereotaxis Q2 EPS $(0.05) Beats $(0.06) Estimate, Sales $7.670M Miss $8.350M Estimate

Stereotaxis Files Prospectus Related To Resale Of 108.87M Shares Of Common Stock By Selling Stockholders

Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5

Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript

Stereotaxis Inc (NYSEARCA:STXS) Slides 6% After Q1 Revenue Miss Despite Narrower-Than-Expected Loss

Stereotaxis Q1 2026 Earnings Call Transcript

Stereotaxis Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $6.291M Miss $8.620M Estimate

Stereotaxis, Inc. (STXS) M&A Call Transcript

Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover

Stereotaxis To Acquire Robocath, A Venture-Backed Producer Of Robotic Technologies For Interventional Cardiology And Neurointerventions; Terms Not Disclosed

Stereotaxis Receives FDA 510(k) Clearance For Synchrony System

STX Semiconductor Co. Files Prospectus To Offer Up To $100M In Debt, Equity, Warrants, Rights, And Units

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks

STEREOTAXIS INC (NYSEARCA:STXS) Posts Narrower-Than-Expected Q4 Loss Despite Revenue Miss

Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript

Stereotaxis Q4 Earnings Summary & Key Takeaways

Stereotaxis Q4 EPS $(0.06), Inline, Sales $8.642M Miss $9.080M Estimate

Preview: Stereotaxis's Earnings